AI-powered nodule detection, reporting, and patient management for enhanced
efficiency and accuracy in lung cancer diagnosis
DeepHealth Lung is an AI-powered solution designed to enhance
lung cancer
diagnosis and reporting. It integrates seamlessly into existing Picture Archiving and
Communication Systems (PACS), offering both onsite and cloud deployment options to minimize
workflow disruptions. Trained on over 40,000 scans, DeepHealth Lung automates the detection,
classification, quantification, and growth assessment of pulmonary nodules, identifying
solid
and sub-solid nodules ranging from 3 to 30mm with 95% sensitivity and no more than two false
positives per scan.
The system provides accurate measurements of nodule diameters
and volumes, and can automatically retrieve prior scans to calculate growth percentage and
volume doubling time. Widely adopted across nearly 100 locations in the UK and EU, including
41 out
of 45 sites in the UK’s Targeted Lung Health Checks program, DeepHealth Lung processes over
50,000 scans monthly, delivering standardized, customizable, and shareable lung nodule
reports to support
efficient clinical workflows.
“I have reduced my chest CT reporting time by
about 50%. The volumetry is also fantastic; it saves me from manually performing the
analysis. Ultimately, a much more robust nodule follow-up –in half the time.”
Dr. Katharine Johnson
Consultant Radiologist at Salisbury NHS (UK)
“I love the detection indications. It’s a simple
yet effective solution that really helps me to report nodules faster. I know exactly where
to find them.”
Dr. Caroline McCann
Responsible Radiologist, Liverpool Heart and Chest Hospital (UK)
Please accept
statistics and marketing
cookies to watch this video. Change consent
Beyond The Diagnosis: Transforming Cancer Care Through
Innovation
Find out how those who live with and work with cancer are rewriting the
narrative in a brand-new digital series presented by Union for International Cancer Control and
produced for them by BBC StoryWorks Commercial Productions.
The series explores innovative solutions for cancer prevention, diagnosis,
treatment and care, and spotlights DeepHealth’s role in transforming lung cancer screening.
We are only beginning to harness AI’s transformative potential, not only to improve disease detection but also to reduce unnecessary imaging and ensure high-quality radiology care is available and accessible for more patients. Find out what five AI trends in radiology that we expect to see more of in the not-too-distant future.
LOS ANGELES, Nov. 27, 2023 — RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services, today announces the launch of DeepHealth, a health informatics portfolio designed to dramatically drive efficiency and transform radiology’s role in healthcare.
Meet DeepHealth at SBI 2025 and discover SmartMammo™, our AI-powered breast cancer detection solution for greater accuracy and precision in mammogram interpretation. We’re proud to join the SBI community in celebrating the Society’s 40th anniversary with a rich and forward-looking program.
Disclaimers:
DeepHealth Lung is manufactured as Veye Lung Nodules by Aidence BV for DeepHealth Inc., and
DeepHeath Lung Tracker is manufactured as Veye Clinic by Aidence BV for DeepHealth Inc.
Not all products and functionalities are commercially available in all countries. For clearance and commercial
availability in your geography of functionalities listed and compatibility with other systems, please contact us.